AI-driven immunotherapy booster design
At Sift, we leverage AI and high-throughput cellular screening to discover & design immunotherapy boosters to significantly extend cancer patient survival.
At Sift, we leverage AI and high-throughput cellular screening to discover & design immunotherapy boosters to significantly extend cancer patient survival.
